$ALOT
AstroNova, Inc.

2016 Q3 Form 10-Q Financial Statement

#000119312516708330 Filed on September 13, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2015 Q3
Revenue $25.34M $23.94M
YoY Change 5.85% 7.03%
Cost Of Revenue $15.03M $14.09M
YoY Change 6.68% 10.29%
Gross Profit $10.31M $9.846M
YoY Change 4.66% 2.68%
Gross Profit Margin 40.67% 41.13%
Selling, General & Admin $6.802M $6.447M
YoY Change 5.51% 8.43%
% of Gross Profit 66.01% 65.48%
Research & Development $1.755M $1.565M
YoY Change 12.14% 5.81%
% of Gross Profit 17.03% 15.89%
Depreciation & Amortization $630.0K $490.0K
YoY Change 28.57% -7.55%
% of Gross Profit 6.11% 4.98%
Operating Expenses $8.557M $8.012M
YoY Change 6.8% 7.91%
Operating Profit $1.748M $1.834M
YoY Change -4.69% -15.25%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $40.00K $21.00K
YoY Change 90.48% -74.7%
Pretax Income $1.788M $1.855M
YoY Change -3.61% -17.45%
Income Tax $496.0K $687.0K
% Of Pretax Income 27.74% 37.04%
Net Earnings $1.292M $1.168M
YoY Change 10.62% -18.61%
Net Earnings / Revenue 5.1% 4.88%
Basic Earnings Per Share $0.17 $0.16
Diluted Earnings Per Share $0.17 $0.16
COMMON SHARES
Basic Shares Outstanding 7.418M shares 7.278M shares
Diluted Shares Outstanding 7.587M shares 7.469M shares

Balance Sheet

Concept 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.80M $18.30M
YoY Change 30.05% -34.64%
Cash & Equivalents $14.90M $5.056M
Short-Term Investments $8.900M $13.30M
Other Short-Term Assets $1.800M $7.600M
YoY Change -76.32% -5.0%
Inventory $17.57M $13.94M
Prepaid Expenses
Receivables $15.23M $15.22M
Other Receivables $200.0K $400.0K
Total Short-Term Assets $58.53M $55.51M
YoY Change 5.43% -16.59%
LONG-TERM ASSETS
Property, Plant & Equipment $9.303M $8.905M
YoY Change 4.47% 14.42%
Goodwill $4.521M $4.522M
YoY Change -0.02% 356.31%
Intangibles $6.284M
YoY Change 106.1%
Long-Term Investments
YoY Change
Other Assets $13.03M $10.98M
YoY Change 18.73% 2644.5%
Total Long-Term Assets $22.34M $19.88M
YoY Change 12.34% 321.43%
TOTAL ASSETS
Total Short-Term Assets $58.53M $55.51M
Total Long-Term Assets $22.34M $19.88M
Total Assets $80.86M $75.40M
YoY Change 7.25% -4.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.362M $3.369M
YoY Change 59.16% 22.33%
Accrued Expenses $1.922M $2.464M
YoY Change -22.0% -53.51%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.48M $8.873M
YoY Change 18.16% 2.97%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $1.000M $1.100M
YoY Change -9.09% 10.0%
Total Long-Term Liabilities $1.000M $1.100M
YoY Change -9.09% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.48M $8.873M
Total Long-Term Liabilities $1.000M $1.100M
Total Liabilities $11.53M $10.02M
YoY Change 15.14% 1.83%
SHAREHOLDERS EQUITY
Retained Earnings $43.49M $41.09M
YoY Change 5.83% 6.21%
Common Stock $47.31M $479.0K
YoY Change 9777.24% 0.84%
Preferred Stock
YoY Change
Treasury Stock (at cost) $20.64M $19.60M
YoY Change 5.28% 49.74%
Treasury Stock Shares 2.366M shares 2.294M shares
Shareholders Equity $69.33M $65.38M
YoY Change
Total Liabilities & Shareholders Equity $80.86M $75.40M
YoY Change 7.25% -4.63%

Cashflow Statement

Concept 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income $1.292M $1.168M
YoY Change 10.62% -18.61%
Depreciation, Depletion And Amortization $630.0K $490.0K
YoY Change 28.57% -7.55%
Cash From Operating Activities $1.470M $1.190M
YoY Change 23.53% -843.75%
INVESTING ACTIVITIES
Capital Expenditures -$180.0K -$640.0K
YoY Change -71.88% 10.34%
Acquisitions
YoY Change
Other Investing Activities -$80.00K -$4.110M
YoY Change -98.05% -207.59%
Cash From Investing Activities -$260.0K -$4.750M
YoY Change -94.53% -247.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -480.0K -460.0K
YoY Change 4.35% 53.33%
NET CHANGE
Cash From Operating Activities 1.470M 1.190M
Cash From Investing Activities -260.0K -4.750M
Cash From Financing Activities -480.0K -460.0K
Net Change In Cash 730.0K -4.020M
YoY Change -118.16% -245.13%
FREE CASH FLOW
Cash From Operating Activities $1.470M $1.190M
Capital Expenditures -$180.0K -$640.0K
Free Cash Flow $1.650M $1.830M
YoY Change -9.84% 335.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000 shares
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
46822000
CY2016Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
8864000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14900000
CY2016Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
2798000
CY2012Q1 alot Debt Received Upon Sale Of Operation
DebtReceivedUponSaleOfOperation
1000000
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7465097 shares
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5056000
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2445000
CY2016Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
5910000
CY2016Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6880000
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
30822000
CY2016Q3 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
14774000
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9799794 shares
CY2016Q3 us-gaap Assets
Assets
80862000
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
769000
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
774000
CY2016Q3 us-gaap Assets Current
AssetsCurrent
58525000
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
803000
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15228000
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
490000
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
715000
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5362000
CY2016Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
490000
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
706000
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-834000
CY2016Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
99000
CY2016Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1922000
CY2016Q3 us-gaap Loans Receivable Basis Spread On Variable Rate
LoansReceivableBasisSpreadOnVariableRate
0.02 pure
CY2016Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1258000
CY2016Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9000000
CY2016Q3 us-gaap Inventory Gross
InventoryGross
22056000
CY2016Q3 us-gaap Inventory Net
InventoryNet
17566000
CY2016Q3 us-gaap Liabilities
Liabilities
11534000
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80862000
CY2016Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5622000
CY2016Q3 us-gaap Goodwill
Goodwill
4521000
CY2016Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1063000
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10484000
CY2016Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
93000
CY2016Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
10000000
CY2016Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
11993000
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13034000
CY2016Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
951000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2807040
CY2016Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4490000
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9303000
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
40125000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.64
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
69328000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.88
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
437606 shares
CY2016Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
265000
CY2016Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
578000
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
43487000
CY2016Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2365636 shares
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1827000
CY2016Q3 us-gaap Treasury Stock Value
TreasuryStockValue
20637000
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2298670
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
703181 shares
CY2016Q3 alot Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
3 pure
CY2016Q3 alot Funded Debt To Adjusted Ebitda Ratio
FundedDebtToAdjustedEbitdaRatio
1.25 pure
CY2016Q3 alot Number Of Installments
NumberOfInstallments
16 Installment
CY2016Q3 alot Amount Of Reserve For Settlement Of Liability
AmountOfReserveForSettlementOfLiability
261000
CY2016Q3 alot Line Of Credit Receivable Current
LineOfCreditReceivableCurrent
140000
CY2016Q3 alot Revolving Line Of Credit Facility Issued Maximum Capacity
RevolvingLineOfCreditFacilityIssuedMaximumCapacity
600000
CY2014Q1 alot Product Replacement Cost Charged Against Reserve
ProductReplacementCostChargedAgainstReserve
411000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7958000
CY2016Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3436000
CY2016Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
4340000
CY2016Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6880000
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2016Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29906000
CY2016Q1 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
14716000
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9666290 shares
CY2016Q1 us-gaap Assets
Assets
77963000
CY2016Q1 us-gaap Assets Current
AssetsCurrent
54514000
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000 shares
CY2016Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
45675000
CY2016Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
10376000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10043000
CY2016Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
3049000
CY2016Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15325000
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
483000
CY2016Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3192000
CY2016Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
529000
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-975000
CY2016Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
78000
CY2016Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2209000
CY2016Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
900000
CY2016Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7491000
CY2016Q1 us-gaap Inventory Gross
InventoryGross
18713000
CY2016Q1 us-gaap Inventory Net
InventoryNet
14890000
CY2016Q1 us-gaap Liabilities
Liabilities
10590000
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77963000
CY2016Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5980000
CY2016Q1 us-gaap Goodwill
Goodwill
4521000
CY2016Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
1025000
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
9548000
CY2016Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
92000
CY2016Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
10197000
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13642000
CY2016Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
964000
CY2016Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
191000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3083000
CY2016Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3823000
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9807000
CY2016Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
39713000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
67373000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.00
CY2016Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
182000
CY2016Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
591000
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
42212000
CY2016Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
2323545 shares
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3539000
CY2016Q1 us-gaap Treasury Stock Value
TreasuryStockValue
20022000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
657936 shares
CY2016Q1 alot Line Of Credit Receivable Current
LineOfCreditReceivableCurrent
150000
CY2012Q1 alot Loan Receivable Interest Rate Stated Percentage
LoanReceivableInterestRateStatedPercentage
0.0375 pure
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
424100 shares
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2902000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
331000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3241000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
946000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2250000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
194000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
27268000
us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
4000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-18000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.327 pure
us-gaap Sales Revenue Net
SalesRevenueNet
46144000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
863000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
254000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
5003000
us-gaap Gross Profit
GrossProfit
18876000
us-gaap Operating Expenses
OperatingExpenses
15594000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Net Income Loss
NetIncomeLoss
2378000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3536000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-6567000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-113000
us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
208000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1067000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
7360000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-128000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1646000
us-gaap Operating Income Loss
OperatingIncomeLoss
3282000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
3127000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1022000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-825000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-15000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-842000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
264000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1158000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
4159000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1291000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7459000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.020 pure
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
190676 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7269000 shares
us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
135000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3361000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.227 pure
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
144000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8992000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.016 pure
us-gaap Share Based Compensation
ShareBasedCompensation
444000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Restricted Stock Expense
RestrictedStockExpense
296000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
191000
alot Proceeds From Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromPaymentsForIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
197000
dei Entity Registrant Name
EntityRegistrantName
AstroNova, Inc.
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
468121 shares
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000008146
dei Document Period End Date
DocumentPeriodEndDate
2016-07-30
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4857000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
185000
us-gaap Fair Value Inputs Discount Rate
FairValueInputsDiscountRate
0.155 pure
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Amendment Flag
AmendmentFlag
false
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3676000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1255000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2452000
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
358000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
29671000
us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
6000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
270000
us-gaap Fair Value Measurements Significant Assumptions
FairValueMeasurementsSignificantAssumptions
Key assumptions include (1) a weighted average cost of capital of 15.5%; (2) a range of earnings projections from $110,000-$700,000 and (3) a range of contract renewal probability from 30%-100%.
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.296 pure
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
141000
us-gaap Sales Revenue Net
SalesRevenueNet
49449000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
400000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Net Income Loss
NetIncomeLoss
2311000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3283000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1332000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
134000
us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
188000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-127000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1921000
us-gaap Gross Profit
GrossProfit
19778000
us-gaap Operating Expenses
OperatingExpenses
16483000
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2017-01-31
us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
Any borrowings made under this line of credit bear interest at either a fluctuating base rate equal to the highest of (i) the Prime Rate, (ii) 1.50% above the daily one month LIBOR, and (iii) the Federal Funds Rate in effect plus 1.50% or at a fixed rate of LIBOR plus an agreed upon margin of between 0% and 2.25%, based on the Company's funded debt to EBITDA ratio as defined in the agreement.
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
141000
us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2656000
us-gaap Operating Income Loss
OperatingIncomeLoss
3295000
us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
0
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
400000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1036000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1043000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
7000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
995000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
314000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
972000
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(1) Overview</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> On September&#xA0;25, 2015, Astro-Med, Inc. announced it would immediately begin doing business as AstroNova on a worldwide basis. The name change is part of the plan to modernize the Company and effectively communicate our strategy. The AstroNova name and brand emphasizes our traditional strengths in aerospace and acknowledges our expanding presence in test&#xA0;&amp; measurement, product identification and other new areas where we can apply our data visualization technology. On May&#xA0;18, 2016, the name change was formally approved by the Company&#x2019;s shareholders, and the Company&#x2019;s Restated Articles of Incorporation were amended to officially change the Company&#x2019;s name to AstroNova, Inc. The Company&#x2019;s common stock trades on the NASDAQ Global Market stock exchange under its new name, AstroNova, Inc., using the ticker symbol, ALOT.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Headquartered in West Warwick, Rhode Island, AstroNova, Inc. leverages its expertise in data visualization technologies to design, develop, manufacture and distribute a broad range of specialty printers and data acquisition and analysis systems. Our products are distributed through our own sales force and authorized dealers in the United States. We also sell to customers outside of the United States primarily through our Company offices in Canada, China, Europe, Mexico and Southeast Asia as well as through independent dealers and representatives. AstroNova, Inc. products are used around the world in a wide range of aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation applications.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The business consists of two segments, Product Identification (previously known as our QuickLabel segment), which includes products sold under the QuickLabel<sup style="FONT-SIZE: 11px; VERTICAL-ALIGN: top">&#xAE;</sup>&#xA0;brand name, and Test&#xA0;&amp; Measurement which includes products sold under the AstroNova&#x2122; brand name.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Products sold under the QuickLabel brand are used in industrial and commercial product packaging and automatic identification applications to digitally print custom labels and other visual identification marks on demand. Products sold under the AstroNova Test&#xA0;&amp; Measurement brand acquire and record visual and electronic signal data from local and networked data streams and sensors. The recorded data is processed and analyzed and then stored and presented in various visual output formats. In the aerospace market, the Company has a long history of using its data visualization technologies to provide high-resolution printers for use in airborne applications.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Unless otherwise indicated, references to &#x201C;AstroNova,&#x201D; the &#x201C;Company,&#x201D; &#x201C;we,&#x201D; &#x201C;our,&#x201D; and &#x201C;us&#x201D; in this Quarterly Report on Form&#xA0;10-Q refer to AstroNova, Inc. and its consolidated subsidiaries.</p> </div>
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
4383000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
377000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
67757 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7560000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M
us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
97000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.019 pure
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.79
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
172022 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y1M6D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.71
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.43
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7388000 shares
dei Trading Symbol
TradingSymbol
ALOT
us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
52000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3199000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.282 pure
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
168000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
117000 shares
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9608000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.014 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
975 shares
us-gaap Share Based Compensation
ShareBasedCompensation
546000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
3023 shares
us-gaap Restricted Stock Expense
RestrictedStockExpense
372000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
8.98
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1135000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 Segments
alot Period To Receive Lower Product Prices From Supplier Description
PeriodToReceiveLowerProductPricesFromSupplierDescription
Through fiscal 2017
alot Non Employee Director Received Restricted Stock Award Value
NonEmployeeDirectorReceivedRestrictedStockAwardValue
20000
alot Reservation Of Shares Under Employee Stock Purchase Plan
ReservationOfSharesUnderEmployeeStockPurchasePlan
247500 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.44
CY2015Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4664000
alot Maximum Disposal Restriction As Percentage Of Restricted Stock Units
MaximumDisposalRestrictionAsPercentageOfRestrictedStockUnits
0.50 pure
alot Loan Receivable Date Considered For Interest Payments
LoanReceivableDateConsideredForInterestPayments
2013-01-30
alot Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
2 Equity_Plan
alot Unrecognized Tax Benefits Increases Resulting From Disqualifying Dispositions
UnrecognizedTaxBenefitsIncreasesResultingFromDisqualifyingDispositions
39000
alot Proceeds From Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromPaymentsForIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
-7000
CY2014Q1 alot Settlement Amount Received From Supplier For Recovery Of Cost And Expenses
SettlementAmountReceivedFromSupplierForRecoveryOfCostAndExpenses
450000
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M6D
CY2013Q2 alot Estimated Replacement Cost Of Product
EstimatedReplacementCostOfProduct
672000
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.43
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.86
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
424100 shares
CY2015Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1783000
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1050000
CY2015Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
105000
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
14092000
CY2015Q3 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
3000
CY2015Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.370 pure
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
23938000
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
21000
CY2015Q3 us-gaap Gross Profit
GrossProfit
9846000
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
8012000
CY2015Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
1168000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1855000
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-122000
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-118000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1834000
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
4000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
687000
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7469000 shares
CY2015Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
190934 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7278000 shares
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1565000
CY2015Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
70000
CY2015Q3 us-gaap Share Based Compensation
ShareBasedCompensation
301000
CY2015Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
228000
CY2015Q3 alot Fees To Non Employee Director
FeesToNonEmployeeDirector
7000
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
413121 shares
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1748000
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
9000
CY2016Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2025000
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1108000
CY2016Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
179000
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
15034000
CY2016Q3 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
3000
CY2016Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.277 pure
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
25339000
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
40000
CY2016Q3 us-gaap Gross Profit
GrossProfit
10305000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
8557000
CY2016Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
1292000
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1788000
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-193000
CY2016Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-184000
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
496000
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7587000 shares
CY2016Q3 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
97000
CY2016Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
168300 shares
CY2016Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7418000 shares
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1755000
CY2016Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
87000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.46
CY2016Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4777000
CY2016Q3 us-gaap Share Based Compensation
ShareBasedCompensation
232000
CY2016Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
142000
CY2016Q3 alot Unrecognized Tax Benefits Increases Resulting From Disqualifying Dispositions
UnrecognizedTaxBenefitsIncreasesResultingFromDisqualifyingDispositions
39000
CY2016Q3 alot Non Employee Director Received Restricted Stock Award Shares
NonEmployeeDirectorReceivedRestrictedStockAwardShares
8262 shares

Files In Submission

Name View Source Status
0001193125-16-708330-index-headers.html Edgar Link pending
0001193125-16-708330-index.html Edgar Link pending
0001193125-16-708330.txt Edgar Link pending
0001193125-16-708330-xbrl.zip Edgar Link pending
alot-20160730.xml Edgar Link completed
alot-20160730.xsd Edgar Link pending
alot-20160730_cal.xml Edgar Link unprocessable
alot-20160730_def.xml Edgar Link unprocessable
alot-20160730_lab.xml Edgar Link unprocessable
alot-20160730_pre.xml Edgar Link unprocessable
d218619d10q.htm Edgar Link pending
d218619dex101.htm Edgar Link pending
d218619dex102.htm Edgar Link pending
d218619dex103.htm Edgar Link pending
d218619dex104.htm Edgar Link pending
d218619dex105.htm Edgar Link pending
d218619dex106.htm Edgar Link pending
d218619dex107.htm Edgar Link pending
d218619dex108.htm Edgar Link pending
d218619dex109.htm Edgar Link pending
d218619dex311.htm Edgar Link pending
d218619dex312.htm Edgar Link pending
d218619dex321.htm Edgar Link pending
d218619dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending